- Home
- KR vs ZTS Comparison
KR vs ZTS Comparison
Compare KR & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KR | ZTS |
|---|---|---|
| Founded | 1883 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1B | 32.5B |
| IPO Year | 2007 | 2012 |
Fundamental Metrics
Financial Performance| Metric | KR | ZTS |
|---|---|---|
| Price | $57.34 | $77.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $74.25 | ★ $154.18 |
| AVG Volume (30 Days) | ★ 6.8M | 4.6M |
| Earning Date | 03-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.09% | 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | ★ 1.46 | 1.42 |
| Revenue | ★ $147,642,000,000.00 | $9,467,000,000.00 |
| Revenue This Year | $4.39 | $5.63 |
| Revenue Next Year | $2.30 | $4.77 |
| P/E Ratio | ★ $38.82 | $52.39 |
| Revenue Growth | 0.35 | ★ 2.28 |
| 52 Week Low | $54.15 | $71.47 |
| 52 Week High | $76.58 | $160.48 |
Technical Indicators
Market Signals| Indicator | KR | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 55.24 |
| Support Level | $55.20 | $73.42 |
| Resistance Level | $64.44 | $82.66 |
| Average True Range (ATR) | 1.35 | 2.16 |
| MACD | 0.06 | 0.32 |
| Stochastic Oscillator | 43.72 | 75.52 |
Price Performance
Historical ComparisonAbout KR Kroger Company (The)
Founded in 1883, Kroger is the largest pure-play supermarket operator in the United States, operating roughly 2,700 stores across more than 30 banners. Kroger's business is primarily grocery-led (roughly 78% of sales), spanning fresh food and private-label offerings, complemented by fuel centers (9%) and pharmacies (12%). The firm also generates income from advertising, data analytics, and manufacturing.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.